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1783nflammatory Biomarkers for Predicting Outcomes After Percutaneous
Coronary Interventioniampaolo Niccoli, Rocco A. Montone, Giuseppe Ferrante, Filippo Crea
he main adverse reactions to coronary stents are in-stent restenosis and stent thrombosis.
uch of the risk for these events can be attributed to procedural factors, but individual
usceptibility may also play an important role. The pathogenesis of these late events seems to
e related to delayed healing and possibly an allergic reaction to the polymer, a process in
hich eosinophils may play an important role by enhancing restenosis and thrombosis.
iccoli and colleagues review the evidence that suggests that high-risk individuals can bedentified through biomarkers related to inflammatory pathways.CLINICAL RESEARCH LINICAL TRIALS
1794ndividualized Heparin and Protamine Dosing in
Infants Undergoing Cardiac Surgery Reduces Complicationsolleen E. Gruenwald, Cedric Manlhiot, Anthony K. Chan, Lynn Crawford-Lean, Celeste Foreman,
elen M. Holtby, Glen S. Van Arsdell, Ross Richards, Helen Moriarty, Brian W. McCrindle
ctivated clotting time (ACT) is traditionally used to monitor heparin-induced
nticoagulation during cardiopulmonary bypass (CPB), but it is insensitive to hemodilution,
ypothermia, and decreased platelet function. Gruenwald and colleagues randomized
0 infants 1 year of age undergoing CPB to weight-based anticoagulation management
tilizing ACT or individualized management with the Hemostasis Management System Plus
HMS) (Medtronic Inc., Minneapolis, Minnesota). The use of the HMS device with a
odified protocol for infants resulted in more stable anti-Xa levels during CPB and improved
ost-operative outcomes. This study supports the use of the HMS device, with a modified
rotocol for infants 1 year of age, for heparin and protamine management during CPB.(continued on page A-22)
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ETHEROSCLEROSIS1803Particulate Air Pollution Linked to Increased CIMTarcus Bauer, Susanne Moebus, Stefan Möhlenkamp, Nico Dragano, Michael Nonnemacher,
iriam Fuchsluger, Christoph Kessler, Hermann Jakobs, Michael Memmesheimer, Raimund Erbel,
arl-Heinz Jöckel, Barbara Hoffmann, on behalf of the HNR Study Investigative Group
auer and colleagues investigated whether urban particulate matter (PM) air pollution
s associated with carotid intima-media thickness (CIMT), a marker of subclinical atheroscle-
osis. Baseline data from a population-based cohort of almost 5,000 participants was linked to
esidential long-term exposure to PM from geographic studies, and the distance from the
ome to high-traffic freeways was also calculated. Higher exposure to fine particles 10 m
nd particularly 2.5 m (PM2.5) as well as distance to high traffic were all associated with
reater CIMT. This study suggests a link between long-term exposure to fine PM air pollu-
ion and atherosclerosis.ditorial Comment: Joel D. Kaufman, p. 1809ARDIAC IMAGING1812Circumferential Strain Rate Predicts Outcomes After MIhung-Lieh Hung, Anil Verma, Hajime Uno, Sung-Hee Shin,
ikhail Bourgoun, Amira H. Hassanein, John J. McMurray, Eric J. Velazquez,
ars Kober, Marc A. Pfeffer, Scott D. Solomon, for the VALIANT Investigators
merging echocardiographic techniques, including speckle-tracking imaging-derived strain
nd strain rate (SR), may more accurately reflect intrinsic measures of myocardial contractility.
ung and colleagues examined the clinical prognostic value of longitudinal and circum-
erential SR in predicting various clinical outcomes and subsequent left ventricular (LV)
emodeling after high-risk myocardial infarction (MI). Both were strong predictors, with
ongitudinal SR adding incremental value in the prediction of all-cause mortality beyond
jection fraction. Circumferential SR, an assessment of short-axis function, further helped
dentify patients at risk of adverse LV remodeling, suggesting that preserved circumferential
unction may restrain ventricular enlargement post-MI.
ditorial Comment: Luc A. Piérard, Patrizio Lancellotti, p. 1823(continued on page A-25)
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EARDIAC RESYNCHRONIZATION
1826he REVERSE Substudy: Benefits of CRT More Pronounced in
Nonischemic Patientsecilia Linde, William T. Abraham, Michael R. Gold, Claude Daubert,
n behalf of the REVERSE Study Group
he REVERSE (REsynchronization reVErses Remodeling in Systolic Left vEntricular
ysfunction) trial enrolled subjects with New York Heart Association functional class I and
I heart failure with QRS 120 ms and left ventricular (LV) ejection fraction 40% of either
onischemic (non-ischemic heart disease [IHD]) or IHD etiology. All subjects received a
ardiac resynchronization therapy (CRT) device, but were randomized to CRT-ON or
RT-OFF. In non-IHD patients, 10% worsened with CRT-ON compared with 19% with
RT-OFF. In IHD patients, 20% worsened in the CRT-ON group compared with 24% in
he CRT-OFF group. This substudy of REVERSE shows that CRT reverses LV
emodeling, with a more pronounced effect in non-IHD patients.EART FAILURE1832Real-Time Dynamic CO Administration May Be Useful for Central Sleep Apnea2
lberto Giannoni, Resham Baruah, Keith Willson, Yoseph Mebrate, Jamil Mayet,
ichele Emdin, Alun D. Hughes, Charlotte H. Manisty, Darrel P. Francis
ariations in end-tidal carbon dioxide (et-CO2) drive the ventilatory oscillations of periodic
reathing (PB) and central sleep apnea (CSA) in heart failure (HF). Giannoni and colleagues
eveloped a dynamic CO2 administration system and tested it on healthy volunteers and then
n subjects with HF. In HF patients, constant CO2 administration attenuated PB but
ncreased mean et-CO2 and ventilation. Dynamic CO2 administration reduced oscillations
n et-CO2 by 43% and ventilatory oscillations by 68%. Dynamic CO2 administration, ad-
inistered at an appropriate time during PB, can significantly reduce oscillations in et-CO2
nd ventilation, while limiting undesirable increases in et-CO2 and ventilation.
ditorial Comment: Olaf Oldenburg, Dieter Horstkotte, p. 1838(continued on page A-26)
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1840bnormal Vascular Response to Mental Stress in Patients With a History
of Apical Ballooning Syndromelizabeth A. Martin, Abhiram Prasad, Charanjit S. Rihal, Lilach O. Lerman, Amir Lerman
pical ballooning syndrome (ABS), also known as tako-tsubo cardiomyopathy, is a transient
ardiomyopathy that occurs predominantly in post-menopausal women and seems to be
riggered by acute mental stress. Martin and colleagues tested the vascular and endothelial
unctional responses to acute mental stress in subjects with a history of ABS and compared
hem with those of patients with a history of a myocardial infarction (MI) or healthy control
ubjects. Forearm reactive hyperemia and vascular responses to acute mental stress were
easured using peripheral arterial tonometry (PAT). Reactive hyperemia and PAT scores
ollowing mental stress were significantly lower in ABS patients compared with both control
roups. These findings implicate vasomotor dysfunction during mental stress in the
athogenesis of ABS.PRE-CLINICAL RESEARCH RE-CLINICAL RESEARCH
1847Novel MCP-1/CCL2 Competitor Limits
Neointima Formation and Ischemia-Reperfusion Injury in Micelisa A. Liehn, Anna-Maria Piccinini, Rory R. Koenen, Oliver Soehnlein, Tiziana Adage,
oxana Fatu, Adelina Curaj, Alexandra Popescu, Alma Zernecke, Andreas J. Kungl, Christian Weber
iehn and colleagues developed a pro-drug (PA508) that is a variant of monocyte
hemotactic protein-1 (MCP-1/CCL2). In vitro, PA508 did not affect CCR2 receptor
inding but inhibited monocyte migration toward CCL2. In hyperlipidemic apolipoprotein
-deficient mice, PA508 reduced neointimal plaque area and mononuclear cell infiltration
fter wire injury of the carotid artery. In mice that underwent myocardial ischemia
eperfusion, PA508 reduced infarction size and preserved heart function. This agent
epresents a novel pro-drug for the treatment of pathological situations, in which binding
f CCL2 to glycosaminoglycans promotes monocyte migration and infiltration.
